| |
Effects and Recommendation :
Resulting In: Transplant rejection status Octreotide Acetate may reduce serum levels of Cyclosporine.
Monitor patient response and adjust therapy as needed.
Severity of the interaction : 3/6
|
Information on this interaction is found in the following publications :
----------
Product Information. Cyclosporine (Sandostatin). Novartis, 1998.
Publication : Cyclosporine (Sandostatin) by Product Information
> Product Information - -
|
|
|
|
|
